doi: 10.1038/srep10637 (2015)
S., Beitzen-Heineke, W., Bll, B., Hinkelbein, J., Mesters, R
If taste changes significantly impact your quality of life or nutritional status, discuss dose adjustment with your prescriber
According to the MHRA-approved SmPC, the most frequently reported side effects are gastrointestinal in nature and include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (very common) Constipation (very common) Vomiting (very common) Abdominal pain (very common) Headache (very common) Fatigue (common, affecting up to 1 in 10 people) Dyspepsia (indigestion, common) These gastrointestinal effects typically occur during dose escalation and often improve as the body adjusts to the medication
The two primary GLP-1 compounds are semaglutide and tirzepatide
This analysis is the first of its kind to show the most up-to-date 2023 prescription data